Open access
Jul 2026
Deep Learning-Driven Anticancer Drug Discovery: Emodepside as a Potential Therapeutic Candidate for Triple-Negative Breast Cancer
This study demonstrates the viability of the deep learning models to discover structurally novel anticancer agents that are distinct from conventional drugs, thereby expanding the therapeutic arsenal for TNBC patients.
Yiyue Xu, Taotao Dong, Butuo Li et al.
· Journal of Chemical Informat... · 0 citations